OPKO Health, Inc. Assets Held-for-sale, Not Part of Disposal Group, Current
OPKO Health, Inc. (OPK) had Assets Held-for-sale, Not Part of Disposal Group, Current of $87.01 million as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent · last filed 2025-07-31
- 2025-06-30: Assets Held-for-sale, Not Part of Disposal Group, Current $87.01M.
- 2025-03-31: Assets Held-for-sale, Not Part of Disposal Group, Current $87.01M.
- 2024-12-31: Assets Held-for-sale, Not Part of Disposal Group, Current $0.00.
- 2022-12-31: Assets Held-for-sale, Not Part of Disposal Group, Current $0.00.
| Period end | Assets Held-for-sale, Not Part of Disposal Group, Current |
|---|---|
| 2025-06-30 | $87.01M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $87.01M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $0.00 10-Q · filed 2025-07-31 |
| 2022-12-31 | $0.00 10-K · filed 2023-02-27 |
| 2021-12-31 | $314.99M 10-K · filed 2023-02-27 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |